Posted on December 1, 2025
- Earlier this week, Dominion Energy announced that its Coastal Virginia Offshore Wind project is now 66% complete, aiming to supply clean energy to hundreds of thousands of homes by the end of 2026 and expanding generation capacity for local data centers.
- This milestone highlights Dominion’s progress in grid modernization and renewable infrastructure, drawing attention to management’s expectation for a significant rate base increase and stronger future earnings.
- We’ll explore how advancing the Coastal Virginia Offshore Wind project could influence Dominion Energy’s long-term earnings outlook and regulated returns.
The latest GPUs need a type of rare earth metal called Dysprosium and there are only 35 companies in the world exploring or producing it. Find the list for free.
Dominion Energy Investment Narrative Recap
To own shares of Dominion Energy, investors typically need confidence in the company’s ability to deliver steady, regulated returns while managing ambitious clean energy investments and ongoing capital requirements. The latest milestone at the Coastal Virginia Offshore Wind project supports progress toward key catalysts like expanding the rate base and earnings, but it does not materially reduce the most significant near-term risks, primarily the potential for project cost overruns and regulatory uncertainties, which remain the main pressures on margins and returns.
Among recent developments, Dominion’s updated operating earnings guidance of US$3.33 to US$3.48 per share for 2025, along with reaffirmed long-term growth targets, is especially relevant given the continued advancement of major renewable projects. These announcements together reflect management’s outlook for stable earnings growth, yet this strategy’s success remains closely linked to how effectively Dominion can control costs and secure regulatory support for its clean energy investments.
However, it is vital to recognize that unrealized risks around future cost increases from tariffs and supply chain issues…
Read the full narrative on Dominion Energy (it’s free!)
Dominion Energy’s narrative projects $17.8 billion in revenue and $3.6 billion in earnings by 2028. This requires 5.3% yearly revenue growth and a $1.1 billion increase in earnings from the current level of $2.5 billion.
Uncover how Dominion Energy’s forecasts yield a $64.00 fair value, in line with its current price.
Exploring Other Perspectives
D Community Fair Values as at Nov 2025
Simply Wall St Community members’ fair value estimates for Dominion Energy range from US$36.73 to US$64 across three analyses, emphasizing just how much opinions can differ. Paired with ongoing risks around project cost escalations and regulatory recovery, these views show why you may want to compare a broader set of expectations before forming your own outlook.
Explore 3 other fair value estimates on Dominion Energy – why the stock might be worth as much as $64.00!
Build Your Own Dominion Energy Narrative
Disagree with existing narratives? Create your own in under 3 minutes – extraordinary investment returns rarely come from following the herd.
- A great starting point for your Dominion Energy research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Dominion Energy research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Dominion Energy’s overall financial health at a glance.
Contemplating Other Strategies?
Don’t miss your shot at the next 10-bagger. Our latest stock picks just dropped:
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer’s.
- Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
